# Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

> **NCT00303810** · NA · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 567 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide phosphate
- **DRUG:** high-dose chemotherapy
- **DRUG:** lomustine
- **DRUG:** methotrexate
- **DRUG:** thiotepa
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00303810
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2013-12
- **Final completion:** —
- **Target enrollment:** 567 (ACTUAL)
- **Last updated:** 2014-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00303810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00303810, "Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00303810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*